55 unchanged sentences
OTHER INFORMATION
+Added: During the quarter ended December 31, 2023, except as described below, none of our executive officers or directors adopted or terminated a "Rule 10b5-1(c) trading arrangement" or a “non-Rule 10b5-1 trading arrangement” (as each term is defined in Item 408 of Regulation S-K).
+Added: On December 12, 2023 , Justin J.
+Added: Noznesky , our Chief Marketing and Strategy Officer , adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
+Added: Noznesky's plan covers the sale of up to 9,273 shares of our common stock between March 12, 2024 and June 28, 2024.
+Added: Transactions under the plan were based upon pre-established dates and stock price thresholds.
DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS
10 unchanged sentences
The Compensation Committee report required by this item is contained in the Proxy Statement under the heading “Executive Compensation—Report of the Compensation Committee of the Board of Directors” and is incorporated herein by reference.
−Removed: The information required by this item with respect to compensation policies and practices as they relate to the Company’s risk management is contained in the Proxy Statement under the heading “Compensation Discussion and Analysis—Elements of Executive Compensation” and is incorporated herein by reference.
+Added: The information required by this item with respect to compensation policies and practices as they relate to the Company’s risk management is contained in the Proxy Statement under the heading “Compensation Discussion and Analysis” and is incorporated herein by reference.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
15 unchanged sentences
Equity compensation plans approved by security holders (3)
+Added: 1,667,626 $ 33.20 2,237,742
Equity compensation plans not approved by security holders — — —
Total 1,667,626 $ 33.20 2,237,742
−Removed: _________________________
(1) Represents outstanding stock options, restricted stock awards and performance shares as of December 31, 2023.
(2) The weighted average exercise price is calculated without taking into account restricted stock that will become issuable, without any cash consideration or other payment, as vesting requirements are achieved.
−Removed: (3) Amounts include awards under our 2005 Equity Incentive Plan and 2014 Stock Incentive Plan but exclude shares purchased under our 2018 Employee Stock Purchase Plan.
+Added: (3) Amounts include awards under our 2023 Stock Incentive Plan (and prior plans, the 2005 Equity Incentive Plan and 2014 Stock Incentive Plan) but exclude shares purchased under our 2018 Employee Stock Purchase Plan.
The information required by this item with respect to security ownership of certain beneficial owners and management is contained in the Proxy Statement under the heading “Security Ownership of Certain Beneficial Owners and Management” and is incorporated herein by reference.
15 unchanged sentences
10.3# AtriCure, Inc.
−Removed: 2018 Employee Stock Purchase Plan (Amended and Restated effective January 1, 2022 (incorporated by reference to our Quarterly Report on Form 10-Q, filed on November 4, 2021).
+Added: 2014 Stock Incentive Plan (Amended and Restated as of May 25, 2022) (incorporated by reference to our Current Report on Form 8-K filed on May 27, 2022).
+Added: 10.4# AtriCure, Inc.
+Added: 2023 Stock Incentive Plan (incorporated by reference to our Current Report on Form 8-K filed on May 26, 2023).
+Added: 10.5# AtriCure, Inc.
+Added: 2018 Employee Stock Purchase Plan (Amended and Restated as of May 25, 2023) (incorporated by reference to our Current Report on Form 8-K filed on May 26, 2023).
10.6# Form of Change in Control Agreement between AtriCure and AtriCure Executive Officers (incorporated by reference to our Annual Report on Form 10-K filed on March 8, 2013).
1 unchanged sentence
10.8 Lease Agreement Dated August 20, 2014 between LM-VP AtriCure, LLC, as Landlord, and AtriCure, Inc., as Tenant (incorporated by reference to our Current Report on Form 8-K filed on August 25, 2014).
−Removed: 10.7# AtriCure, Inc.
−Removed: 2014 Stock Incentive Plan (Amended and Restated as of May 25, 2022) (incorporated by reference to our Current Report on Form 8-K, filed on May 27, 2022).
+Added: 10.9 JPMorgan Credit Agreement, dated January 5, 2024 (incorporated by reference to our Current Report on Form 8-K filed on January 8, 2024).
10.10# Form of Restricted Stock Award Agreement under the Amended and Restated AtriCure, Inc.
7 unchanged sentences
10.15 Joinder and Third Amendment to Loan and Security Agreement dated September 27, 2019 (incorporated by reference to our Quarterly Report on Form 10-Q filed on October 31, 2019) .
−Removed: 10.14 Fourth Amendment to Loan and Security Agreement dated April 29, 2020 among AtriCure, Inc., Silicon Valley Bank and the other parties named therein (incorporated by reference to our Current Report on Form 8-K filed with the Commission on April 29, 2020) .
+Added: 10.16 Fourth Amendment to Loan and Security Agreement dated April 29, 2020 among AtriCure, Inc., Silicon Valley Bank and the other parties named therein (incorporated by reference to our Current Report on Form 8-K filed on April 29, 2020) .
10.17 Fifth Amendment to Loan and Security Agreement dated February 8, 2021 among AtriCure, Inc., Silicon Valley Bank and the other parties named therein (incorporated by reference to our Annual Report on Form 10-K filed on February 26, 2021).
1 unchanged sentence
10.19# Form of Performance Share Award Agreement for Awards Granted in 2021 (incorporated by reference to our Annual Report on Form 10-K filed on February 26, 2021).
+Added: 10.20# Form of Performance Share Award Agreement for Awards Granted in 2022 (incorporated by reference to our Annual Report on Form 10-K filed on February 22, 2023).
10.21# AtriCure, Inc.
1 unchanged sentence
10.22# Form of Performance Share Award Agreement for Awards Granted in 2023.
−Removed: 14 Code of Conduct.
+Added: 10.23# Form of Restricted Stock Award Agreement under the AtriCure, Inc.
+Added: 2023 Stock Incentive Plan.
+Added: 10.24# Form of Restricted Share Unit Award Agreement under the AtriCure, Inc.
+Added: 2023 Stock Incentive Plan.
+Added: 14 Code of Conduct (incorporated by reference to our Annual Report on Form 10-K filed on February 22, 2023).
+Added: 19 Insider Trading Policy.
21 Subsidiaries of the Registrant.
6 unchanged sentences
Section 1350 by the Chief Financial Officer, as adopted, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
+Added: 97 Incentive Compensation Recoupment Policy.
101.INS XBRL Instance Document
35 unchanged sentences
(Principal Executive Officer)
−Removed: Collar Mark A.
−Removed: Collar Director
/s/ Regina E.
1 unchanged sentence
Groves Director
+Added: /s/ Shlomo Nachman
+Added: Shlomo Nachman
+Added: Shlomo Nachman
Prange Karen N.
11 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.